JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Coya Therapeutics Highlights Strategic Vision Under New CEO, With Key 2025 Milestones Including ALS Trial With Dr. Reddy's Partnership Worth Up To $700M, Emerging Opportunities In Parkinson's And Autoimmune Conditions, And Focus On Non-Dilutive...
Today's Pre-Market Movers and Top Ratings | WMT, LOW, SMCI, GOOGL and More
Labcorp Gets New Finance Chief
Evercore ISI Group Upgrades BioNTech to Outperform, Raises Price Target to $125
Merck Says Injectable Keytruda Succeeded in Late-stage Trial